Reinhard Sarges

Person

Mystic, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Glycogen phosphorylase inhibitors
- Patent number 5,998,463
- Issue date Dec 7, 1999
- Pfizer Inc.
- Bernard Hulin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aminoquinoline derivatives
- Patent number 5,362,743
- Issue date Nov 8, 1994
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indolinone derivatives
- Patent number 5,064,852
- Issue date Nov 12, 1991
- Pfizer Inc.
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolidinedione derivatives in diabetes treatment
- Patent number 5,011,840
- Issue date Apr 30, 1991
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azolidinedione derivatives
- Patent number 4,980,357
- Issue date Dec 25, 1990
- Pfizer Inc.
- Steven W. Goldstein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-in...
- Patent number 4,977,178
- Issue date Dec 11, 1990
- Pfizer Inc.
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indolinone derivatives
- Patent number 4,960,785
- Issue date Oct 2, 1990
- Pfizer Inc.
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-arylsulfonyl-3,4-dihydro-2(1H)-quinoxalinone-1-alkanoic acids, es...
- Patent number 4,940,708
- Issue date Jul 10, 1990
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents
- Patent number 4,879,391
- Issue date Nov 7, 1989
- Pfizer Inc.
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents
- Patent number 4,861,880
- Issue date Aug 29, 1989
- Pfizer Inc.
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
[1,2,4]Triazolo[4,3-a]quinoxaline-4-amine derivatives
- Patent number 4,623,725
- Issue date Nov 18, 1986
- Pfizer Inc.
- Saul B. Kadin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Intermediates for 1,3-disubstituted piperidine compounds as neurole...
- Patent number 4,623,728
- Issue date Nov 18, 1986
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,3-disubstituted piperidine compounds as neuroleptic agents
- Patent number 4,593,037
- Issue date Jun 3, 1986
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivativ...
- Patent number 4,547,501
- Issue date Oct 15, 1985
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivativ...
- Patent number 4,495,187
- Issue date Jan 22, 1985
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroylidene indolone compounds
- Patent number 4,476,307
- Issue date Oct 9, 1984
- Pfizer Inc.
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spi...
- Patent number 4,474,967
- Issue date Oct 2, 1984
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-imide derivatives
- Patent number 4,471,124
- Issue date Sep 11, 1984
- Pfizer Inc.
- John L. Belletire
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imide derivatives
- Patent number 4,442,114
- Issue date Apr 10, 1984
- Pfizer Inc.
- John L. Belletire
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6-Halo-4-chromanamines useful as intermediates to make chiral hydan...
- Patent number 4,419,521
- Issue date Dec 6, 1983
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Intermediates in the preparation of chiral hydantoins
- Patent number 4,348,526
- Issue date Sep 7, 1982
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for lowering sorbitol levels using spiro-imides
- Patent number 4,307,108
- Issue date Dec 22, 1981
- Pfizer Inc.
- John L. Belletire
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of chiral hydantoins
- Patent number 4,286,098
- Issue date Aug 25, 1981
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolone derivatives
- Patent number 4,283,409
- Issue date Aug 11, 1981
- Pfizer Inc.
- John L. Belletire
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydantoin derivatives, anti-diabetic compositions thereof, and meth...
- Patent number 4,273,775
- Issue date Jun 16, 1981
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydantoin derivatives as therapeutic agents
- Patent number 4,258,054
- Issue date Mar 24, 1981
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treating diabetes-associated complications with hydantoin amines
- Patent number 4,248,882
- Issue date Feb 3, 1981
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydantoin derivatives
- Patent number 4,235,911
- Issue date Nov 25, 1980
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical preparations containing coumarin carboxylic acid der...
- Patent number 4,210,667
- Issue date Jul 1, 1980
- Pfizer Inc.
- Reinhard Sarges
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydroquinoline hydantoins for chronic diabetic complications
- Patent number 4,210,756
- Issue date Jul 1, 1980
- Pfizer Inc.
- Reinhard Sarges
- C07 - ORGANIC CHEMISTRY

Reinhard Sarges

Person

Patents Grantslast 30 patents

Glycogen phosphorylase inhibitors

Aminoquinoline derivatives

Indolinone derivatives

Imidazolidinedione derivatives in diabetes treatment

Azolidinedione derivatives

Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-in...

Indolinone derivatives

4-arylsulfonyl-3,4-dihydro-2(1H)-quinoxalinone-1-alkanoic acids, es...

1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents

1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents

[1,2,4]Triazolo[4,3-a]quinoxaline-4-amine derivatives

Intermediates for 1,3-disubstituted piperidine compounds as neurole...

1,3-disubstituted piperidine compounds as neuroleptic agents

Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivativ...

Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivativ...

Heteroylidene indolone compounds

8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spi...

Spiro-imide derivatives

Imide derivatives

6-Halo-4-chromanamines useful as intermediates to make chiral hydan...

Intermediates in the preparation of chiral hydantoins

Method for lowering sorbitol levels using spiro-imides

Process for the preparation of chiral hydantoins

Imidazolone derivatives

Hydantoin derivatives, anti-diabetic compositions thereof, and meth...

Hydantoin derivatives as therapeutic agents

Treating diabetes-associated complications with hydantoin amines

Hydantoin derivatives

Pharmaceutical preparations containing coumarin carboxylic acid der...

Tetrahydroquinoline hydantoins for chronic diabetic complications